These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26242894)

  • 21. Cancer prevention I: introduction.
    Dunn BK; Greenwald P
    Semin Oncol; 2010 Jun; 37(3):190-201. PubMed ID: 20709204
    [No Abstract]   [Full Text] [Related]  

  • 22. A research note regarding "Variation in cancer risk among tissues can be explained by the number of stem cell divisions".
    Tarabichi M; Detours V
    F1000Res; 2016; 5():2044. PubMed ID: 27853514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Science Communication. Backlash greets 'bad luck' cancer study and coverage.
    Couzin-Frankel J
    Science; 2015 Jan; 347(6219):224. PubMed ID: 25593168
    [No Abstract]   [Full Text] [Related]  

  • 25. Understanding mechanisms of cancer initiation and development supports the need for an implementation of primary and secondary cancer prevention.
    Pelosi E; Castelli G; Testa U
    Ann Ist Super Sanita; 2019; 55(4):371-379. PubMed ID: 31850865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancers make their own luck: theories of cancer origins.
    Jassim A; Rahrmann EP; Simons BD; Gilbertson RJ
    Nat Rev Cancer; 2023 Oct; 23(10):710-724. PubMed ID: 37488363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.
    Reimers LL; Sivasubramanian PS; Hershman D; Terry MB; Greenlee H; Campbell J; Kalinsky K; Maurer M; Jayasena R; Sandoval R; Alvarez M; Crew KD
    Breast J; 2015; 21(4):377-86. PubMed ID: 25879521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are Most Cancers Caused by Specific Risk Factors Acting on Tissues With High Underlying Stem Cell Divisions?
    Giovannucci EL
    J Natl Cancer Inst; 2015 Nov; 108(3):. PubMed ID: 26553782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remark to Response of A. V. Lichtenstein.
    Manskikh VN
    Biochemistry (Mosc); 2017 Jan; 82(1):88. PubMed ID: 28320292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evidence-based approach to cancer prevention clinical trials.
    Greenwald P; McDonald SS; Anderson DE
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S43-7. PubMed ID: 12570334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conceptualizing overdiagnosis in cancer screening.
    Marcus PM; Prorok PC; Miller AB; DeVoto EJ; Kramer BS
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Breakthrough in breast cancer chemoprevention].
    Kahán Z; Thurzó L
    Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The origins of cancer robustness and evolvability.
    Tian T; Olson S; Whitacre JM; Harding A
    Integr Biol (Camb); 2011 Jan; 3(1):17-30. PubMed ID: 20944865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do mutational dynamics in stem cells explain the origin of common cancers?
    Crossan GP; Garaycoechea JI; Patel KJ
    Cell Stem Cell; 2015 Feb; 16(2):111-2. PubMed ID: 25658366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer.
    Marin JJ; Sanchez de Medina F; Castaño B; Bujanda L; Romero MR; Martinez-Augustin O; Moral-Avila RD; Briz O
    Drug Metab Rev; 2012 May; 44(2):148-72. PubMed ID: 22497631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted therapies for the prevention of lung cancer.
    Schachter EN; Neuman T
    Drugs Today (Barc); 2007 Dec; 43(12):897-936. PubMed ID: 18174975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem cells: an old idea--a paradigm shift.
    Wicha MS; Liu S; Dontu G
    Cancer Res; 2006 Feb; 66(4):1883-90; discussion 1895-6. PubMed ID: 16488983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk].
    Sanner T; Dybing E
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.